Medicare Enrolled

Dr. David Liao, M.D.,PH.D.

Ophthalmology · Los Angeles, CA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
1245 WILSHIRE BLVD STE 380, Los Angeles, CA 90017
2134838810
In practice since 2007 (19 years)
NPI: 1962541847 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Liao from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Liao? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Liao

Dr. David Liao is an ophthalmology specialist in Los Angeles, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Liao performed 28,753 Medicare services across 3,454 unique beneficiaries.

Between the years covered by Open Payments, Dr. Liao received a total of $6,898 from 17 pharmaceutical and/or device companies across 66 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Liao is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 3% volume in CA $6,898 industry payments

Medicare Practice Summary

Medicare Utilization ↗
28,753
Medicare services
Top 3% in CA for ophthalmology
3,454
Unique beneficiaries
$68
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~1,513 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Eye injection (Vabysmo/faricimab)
An injection of faricimab-svoa, a medication administered in 0.1 mg doses.
20,040 $29 $85
Retinal imaging (OCT scan)
This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye.
2,832 $34 $150
Eye injection for retinal disease
A procedure involving the administration of medication directly into the eye.
1,286 $105 $776
Comprehensive eye exam, established patient
A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider.
1,162 $98 $300
Aflibercept eye injection (Eylea) 1,054 $685 $2,500
Eye exam, established patient, focused
A limited examination of the visual system for an existing patient. The provider focuses on a specific eye-related concern or symptom.
535 $80 $200
Ranibizumab-eqrn injection, 0.1 mg
An injection of the biosimilar medication ranibizumab-eqrn (Cimerli) in a 0.1 mg dose.
517 $220 $700
Bevacizumab injection, 10 mg
Administration of a 10 mg dose of bevacizumab medication via injection.
482 $56 $200
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
295 $128 $300
Extended exam of back of eye with optic nerve drawing
A detailed examination of the posterior section of the eye, including the optic nerve, with documentation through drawing.
104 $11 $170
Ultrasound of eye tissue and structures
A diagnostic imaging test that uses sound waves to create pictures of the eye's internal tissues and structures.
83 $40 $200
Extended eye exam with retinal drawing
A detailed examination of the back of the eye that includes creating a drawing of the retina.
77 $19 $170
Retinal angiography with dye injection
This procedure uses a special camera to examine the blood vessels in the retina after a dye has been injected into the body.
75 $124 $275
Visual field test, extended
A test that maps your complete field of vision to detect blind spots or peripheral vision loss. Extended testing provides a more detailed assessment than a standard visual field exam.
53 $50 $150
Retinal and optic nerve function test
A diagnostic test that measures the function of the retina and optic nerve at multiple specific locations.
34 $79 $137
Vitreous removal between lens and retina
This procedure involves the removal of the vitreous fluid located between the lens and the retina of the eye.
23 $639 $5,500
Retinal and optic nerve function test
A diagnostic test that measures how well the retina and optic nerve are functioning.
18 $115 $204
Comprehensive eye exam, new patient
A comprehensive examination of the visual system performed for a new patient.
16 $81 $350
Retinal laser treatment for leaking blood vessels
This procedure uses a laser to seal leaking blood vessels in the retina. It is performed to prevent vision loss caused by fluid leakage from damaged retinal vessels.
12 $299 $1,900
Retinal membrane and internal limiting membrane removal
A surgical procedure to remove a membrane from the retina along with the internal limiting membrane of the retina.
11 $984 $6,200
Retinal detachment repair with fluid drainage
A surgical procedure to reattach a detached retina by draining excess fluid from the space between the lens and the retina.
11 $1,023 $5,700
Complex detached retina repair with eye fluid drainage
A surgical procedure to repair a detached retina and drain fluid located between the lens and the retina.
11 $1,041 $6,200
Retinal photocoagulation to prevent detachment
This procedure uses laser light to create small burns on the retina. It is performed to help prevent the retina from detaching from the back of the eye.
11 $185 $1,650
Visual evoked potential test
A test that measures how quickly electrical signals travel from the eye to the brain in response to visual stimuli.
11 $62 $200
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$6,898
Total received (2018-2024)
Avg $985/year across 7 years
Top 19% in CA for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
17
Companies
66
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$3,017 (43.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,924 (42.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$957 (13.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$304
2023
$1,242
2022
$792
2021
$2,407
2020
$1,173
2019
$501
2018
$480

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Alcon Vision LLC
$130
Apellis Pharmaceuticals, Inc.
$55
ABBVIE INC.
$54
Genentech USA, Inc.
$51
Biogen, Inc.
$13
Top 3 companies account for 78.7% of 2024 payments
All-time payments by company (2018-2024) ›
Allergan, Inc.
$1,668
Alimera Sciences, Inc.
$1,355
Alcon Vision LLC
$1,079
Regeneron Pharmaceuticals, Inc.
$957
Regeneron Healthcare Solutions, Inc.
$433
Alcon Laboratories Inc
$336
Genentech USA, Inc.
$288
Apellis Pharmaceuticals, Inc.
$259
ABBVIE INC.
$153
Spark Therapeutics, Inc.
$125
EyePoint Pharmaceuticals US, Inc.
$125
Astellas Pharma US Inc
$32
Bausch & Lomb, a division of Bausch Health US, LLC
$25
Aerie Pharmaceuticals, Inc.
$23
Sun Pharmaceutical Industries Inc.
$14
Biogen, Inc.
$13
Allergan Inc.
$12
Top 3 companies account for 59.5% of all-time payments
Associated products mentioned in payments ›
ALPHAGAN P · BYOOVIZ · BromSite (bromfenac ophthalmic solution) 0.075% · Constellation · DEXYCU · EYLEA · ILUVIEN · Lucentis · NGENUITY · OZURDEX · PROLENSA · Rhopressa · SUSVIMO · Syfovre · VABYSMO · Vabysmo
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (44%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in ophthalmology and does not inherently indicate bias, but patients may wish to be aware.

Looking for an ophthalmology specialist in Los Angeles?
Compare ophthalmologists in the Los Angeles area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologists nearby

Geographic Context

Ophthalmologists within 10 mi
788
Per 100K population
8.0
County median income
$87,760
Nearest hospital
PIH HEALTH GOOD SAMARITAN HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Liao is a mixed practice specialist, with above-average Medicare volume (top 3% in CA), with speaking/promotional industry engagement in the top 19% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Liao experienced with eye injection (vabysmo/faricimab)?
Based on Medicare claims data, Dr. Liao performed 20,040 eye injection (vabysmo/faricimab) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Liao receive payments from pharmaceutical companies?
Yes. Dr. Liao received a total of $6,898 from 17 companies across 66 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Liao's costs compare to other ophthalmologists in Los Angeles?
Dr. Liao's average Medicare payment per service is $68. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Liao) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →